Introduction
Brand name: Moxiact
Manufacturer: Astemax Biotech Pvt. Ltd.
Product: Moxifloxacin 0.5% IP eye drop (5 ml)
Moxiact is a sterile ophthalmic solution containing moxifloxacin 0.5% w/v (5 mg per mL), belonging to the fluoroquinolone class of antibiotics. It is indicated for the treatment of bacterial infections of the eye, including bacterial conjunctivitis and other superficial ocular infections caused by susceptible organisms such as Staphylococcus, Streptococcus, Haemophilus, and many Gram‑negative pathogens.
Key features
Broad‑spectrum coverage against common ocular pathogens with good corneal penetration, suitable for both anterior segment infections and peri‑operative prophylaxis.
Used as topical eye drops – typically 1 drop in the affected eye(s) 3 times daily for 5–7 days, or as directed by the ophthalmologist.
Preservative‑free or low‑preservative formulation options (per market‑specific pack) to reduce local irritation, especially in sensitive or post‑surgical eyes.
Main indications
Bacterial conjunctivitis (pink eye), keratitis, and corneal‑surface infections.
Prophylaxis and treatment in external‑eye‑infection settings, including post‑cataract, post‑LASIK, or post‑minor trauma when bacterial contamination is suspected.
Typical use and precautions
Instill 1 drop into the affected eye(s), ensuring correct aseptic technique and avoiding contact of the dropper tip with the eye or eyelids.
